These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

896 related articles for article (PubMed ID: 10422996)

  • 1. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit.
    Leape LL; Cullen DJ; Clapp MD; Burdick E; Demonaco HJ; Erickson JI; Bates DW
    JAMA; 1999 Jul; 282(3):267-70. PubMed ID: 10422996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On-ward participation of a hospital pharmacist in a Dutch intensive care unit reduces prescribing errors and related patient harm: an intervention study.
    Klopotowska JE; Kuiper R; van Kan HJ; de Pont AC; Dijkgraaf MG; Lie-A-Huen L; Vroom MB; Smorenburg SM
    Crit Care; 2010; 14(5):R174. PubMed ID: 20920322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacists on rounding teams reduce preventable adverse drug events in hospital general medicine units.
    Kucukarslan SN; Peters M; Mlynarek M; Nafziger DA
    Arch Intern Med; 2003 Sep; 163(17):2014-8. PubMed ID: 14504113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacist interventions during patient rounds in two intensive care units: Clinical and financial impact.
    Bosma BE; van den Bemt PMLA; Melief PHGJ; van Bommel J; Tan SS; Hunfeld NGM
    Neth J Med; 2018 Apr; 76(3):115-124. PubMed ID: 29667584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A clinical pharmacist-led integrated approach for evaluation of medication errors among medical intensive care unit patients.
    Aghili M; Neelathahalli Kasturirangan M
    JBI Evid Implement; 2021 Mar; 19(1):21-30. PubMed ID: 33570331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unit-based clinical pharmacists' prevention of serious medication errors in pediatric inpatients.
    Kaushal R; Bates DW; Abramson EL; Soukup JR; Goldmann DA
    Am J Health Syst Pharm; 2008 Jul; 65(13):1254-60. PubMed ID: 18574016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of adverse drug events in an academic hospital: a prospective cohort study.
    Aljadhey H; Mahmoud MA; Mayet A; Alshaikh M; Ahmed Y; Murray MD; Bates DW
    Int J Qual Health Care; 2013 Dec; 25(6):648-55. PubMed ID: 24141014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new approach on assessing clinical pharmacists' impact on prescribing errors in a surgical intensive care unit.
    Kessemeier N; Meyn D; Hoeckel M; Reitze J; Culmsee C; Tryba M
    Int J Clin Pharm; 2019 Oct; 41(5):1184-1192. PubMed ID: 31332648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cost-saving effect and prevention of medication errors by clinical pharmacist intervention in a nephrology unit.
    Chen CC; Hsiao FY; Shen LJ; Wu CC
    Medicine (Baltimore); 2017 Aug; 96(34):e7883. PubMed ID: 28834903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterising the complexity of medication safety using a human factors approach: an observational study in two intensive care units.
    Carayon P; Wetterneck TB; Cartmill R; Blosky MA; Brown R; Kim R; Kukreja S; Johnson M; Paris B; Wood KE; Walker J
    BMJ Qual Saf; 2014 Jan; 23(1):56-65. PubMed ID: 24050986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group.
    Bates DW; Cullen DJ; Laird N; Petersen LA; Small SD; Servi D; Laffel G; Sweitzer BJ; Shea BF; Hallisey R
    JAMA; 1995 Jul; 274(1):29-34. PubMed ID: 7791255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preventable adverse drug events in hospitalized patients: a comparative study of intensive care and general care units.
    Cullen DJ; Sweitzer BJ; Bates DW; Burdick E; Edmondson A; Leape LL
    Crit Care Med; 1997 Aug; 25(8):1289-97. PubMed ID: 9267940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost implications of and potential adverse events prevented by interventions of a critical care pharmacist.
    Kopp BJ; Mrsan M; Erstad BL; Duby JJ
    Am J Health Syst Pharm; 2007 Dec; 64(23):2483-7. PubMed ID: 18029956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving antimicrobial dosing in critically ill patients receiving continuous venovenous hemofiltration and the effect of pharmacist dosing adjustment.
    Jiang SP; Xu YY; Ping-Yang ; Wu WF; Zhang XG; Lu XY; Xiao YH; Liang WF; Chen J
    Eur J Intern Med; 2014 Dec; 25(10):930-5. PubMed ID: 25153537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ambulatory Computerized Prescribing and Preventable Adverse Drug Events.
    Overhage JM; Gandhi TK; Hope C; Seger AC; Murray MD; Orav EJ; Bates DW
    J Patient Saf; 2016 Jun; 12(2):69-74. PubMed ID: 26001546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of pharmacist counseling in preventing adverse drug events after hospitalization.
    Schnipper JL; Kirwin JL; Cotugno MC; Wahlstrom SA; Brown BA; Tarvin E; Kachalia A; Horng M; Roy CL; McKean SC; Bates DW
    Arch Intern Med; 2006 Mar; 166(5):565-71. PubMed ID: 16534045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence, preventability, and impact of Adverse Drug Events (ADEs) and potential ADEs in hospitalized children in New Zealand: a prospective observational cohort study.
    Kunac DL; Kennedy J; Austin N; Reith D
    Paediatr Drugs; 2009; 11(2):153-60. PubMed ID: 19301935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of computerized physician order entry and a team intervention on prevention of serious medication errors.
    Bates DW; Leape LL; Cullen DJ; Laird N; Petersen LA; Teich JM; Burdick E; Hickey M; Kleefield S; Shea B; Vander Vliet M; Seger DL
    JAMA; 1998 Oct; 280(15):1311-6. PubMed ID: 9794308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of the TIM program (Transfer ICU Medication reconciliation) on medication transfer errors in two Dutch intensive care units: design of a prospective 8-month observational study with a before and after period.
    Bosma BE; Meuwese E; Tan SS; van Bommel J; Melief PH; Hunfeld NG; van den Bemt PM
    BMC Health Serv Res; 2017 Feb; 17(1):124. PubMed ID: 28183302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacist- versus physician-initiated admission medication reconciliation: impact on adverse drug events.
    Mergenhagen KA; Blum SS; Kugler A; Livote EE; Nebeker JR; Ott MC; Signor D; Sung S; Yeh J; Boockvar KS
    Am J Geriatr Pharmacother; 2012 Aug; 10(4):242-50. PubMed ID: 22819386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.